Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1979 1
1981 1
1986 2
1987 3
1988 1
1989 4
1990 7
1991 9
1992 22
1993 13
1994 7
1995 11
1996 8
1997 10
1998 9
1999 10
2000 5
2001 5
2002 11
2003 12
2004 9
2005 7
2006 9
2007 13
2008 7
2009 5
2010 3
2011 10
2012 6
2013 6
2014 9
2015 7
2016 5
2017 2
2019 3
2020 3
2021 3
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

251 results

Results by year

Filters applied: . Clear all
Page 1
Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
Burchardt NA, Eliassen AH, Shafrir AL, Rosner B, Tamimi RM, Kaaks R, Tworoger SS, Fortner RT. Burchardt NA, et al. Am J Obstet Gynecol. 2022 Jun;226(6):821.e1-821.e26. doi: 10.1016/j.ajog.2021.12.022. Epub 2021 Dec 15. Am J Obstet Gynecol. 2022. PMID: 34921803
In analyses by formulation, current use of formulations containing levonorgestrel in triphasic (hazard ratio, 2.83; 95% confidence interval, 1.98-4.03) and extended cycle regimens (hazard ratio, 3.49; 95% confidence interval, 1.28-9.53) and norgestrel in monophasic regimens (haza …
In analyses by formulation, current use of formulations containing levonorgestrel in triphasic (hazard ratio, 2.83; 95% confidence interval, …
Effects of rimegepant 75 mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants.
Bhardwaj R, Stringfellow JC, Morris B, Croop RS, Bertz RJ. Bhardwaj R, et al. Headache. 2023 May;63(5):652-662. doi: 10.1111/head.14512. Epub 2023 May 4. Headache. 2023. PMID: 37140071 Clinical Trial.
OBJECTIVE: To assess the effect of single and multiple doses of rimegepant 75 mg dose on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol (EE)/norgestimate (NGM) in healthy females of childbearing potential or non-menopausal females …
OBJECTIVE: To assess the effect of single and multiple doses of rimegepant 75 mg dose on the pharmacokinetics of an oral contraceptive conta …
Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
Lucky AW, Henderson TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ. Lucky AW, et al. J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):746-54. doi: 10.1016/s0190-9622(97)70112-9. J Am Acad Dermatol. 1997. PMID: 9366821 Clinical Trial.
OBJECTIVE: Our purpose was to evaluate the efficacy of a triphasic, combination OC (ORTHO TRI-CYCLEN [Ortho-McNeil Pharmaceutical, Raritan, N.J.], norgestimate/ethinyl estradiol) compared with placebo in the treatment of moderate acne vulgaris. ...Each month …
OBJECTIVE: Our purpose was to evaluate the efficacy of a triphasic, combination OC (ORTHO TRI-CYCLEN [Ortho-McNeil Pharmaceutical, Raritan, …
Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
Redmond GP, Olson WH, Lippman JS, Kafrissen ME, Jones TM, Jorizzo JL. Redmond GP, et al. Obstet Gynecol. 1997 Apr;89(4):615-22. doi: 10.1016/S0029-7844(97)00059-8. Obstet Gynecol. 1997. PMID: 9083323 Clinical Trial.
OBJECTIVE: To evaluate the efficacy of a triphasic, combination oral contraceptive (OC), (norgestimate-ethinyl estradiol), in comparison with placebo in the treatment of moderate acne vulgaris. METHODS: Two hundred fifty women were enrolled in a multicenter, …
OBJECTIVE: To evaluate the efficacy of a triphasic, combination oral contraceptive (OC), (norgestimate-ethinyl estradiol
Determination of norgestimate and ethinyl estradiol in tablets by high-performance liquid chromatography.
Lane PA, Mayberry DO, Young RW. Lane PA, et al. J Pharm Sci. 1987 Jan;76(1):44-7. doi: 10.1002/jps.2600760113. J Pharm Sci. 1987. PMID: 3585722
Norgestimate and ethinyl estradiol were extracted from the tablet matrix with methanol containing an internal standard. ...The selectivity of the chromatographic system for intact norgestimate and ethinyl estradiol was demonstrated by res
Norgestimate and ethinyl estradiol were extracted from the tablet matrix with methanol containing an internal standard.
Disposition of norgestimate in the presence and absence of ethinyl estradiol after oral administration to humans.
Weintraub HS, Abrams LS, Patrick JE, McGuire JL. Weintraub HS, et al. J Pharm Sci. 1978 Oct;67(10):1406-8. doi: 10.1002/jps.2600671020. J Pharm Sci. 1978. PMID: 702290
The disposition of radioactivity following oral administration of 14C-norgestimate was compared to that following administration of the drug in combination with 3H-ethinyl estradiol in humans. ...Approximately 50% of the administered radioactivity due to carb …
The disposition of radioactivity following oral administration of 14C-norgestimate was compared to that following administration of t …
UPLC-MS/MS assay for the simultaneous determination of ethinyl estradiol, norgestimate and 17-Desacetyl norgestimate at low pg/mL in human plasma.
Huang MQ, Kang L, Wang W, Skee D, Chen M, Lin ZJ, Verhaeghe T, Weng N. Huang MQ, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Apr 1;1017-1018:1-9. doi: 10.1016/j.jchromb.2016.01.054. Epub 2016 Feb 23. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 26930373
Previously, because of the difficulty of measuring very low levels (pg/mL) of norgestimate (NGM) due to rapid metabolism to its active and major metabolite, 17-Desacetyl norgestimate (DNGM), only DNGM and the co-administered ethinyl estradiol (EE2) wer …
Previously, because of the difficulty of measuring very low levels (pg/mL) of norgestimate (NGM) due to rapid metabolism to its activ …
Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding.
Davis A, Godwin A, Lippman J, Olson W, Kafrissen M. Davis A, et al. Obstet Gynecol. 2000 Dec;96(6):913-20. doi: 10.1016/s0029-7844(00)01029-2. Obstet Gynecol. 2000. PMID: 11084177 Clinical Trial.
OBJECTIVE: To compare the efficacy of a triphasic combination oral contraceptive (OC) containing norgestimate and ethinyl estradiol (E2) and placebo in the treatment of metrorrhagic, menometrorrhagic, oligomenorrheic, and polymenorrheic dysfunctional uterine …
OBJECTIVE: To compare the efficacy of a triphasic combination oral contraceptive (OC) containing norgestimate and ethinyl e
Contraception.
Huggins GR. Huggins GR. Curr Opin Obstet Gynecol. 1990 Apr;2(2):291-5. Curr Opin Obstet Gynecol. 1990. PMID: 2102326 Review.
They contain 1 of 5 synthetic progestogens (derived from 19-nortestosterone) and 1 of 2 estrogens. 3 new progestin compounds are in use in Europe and Asia. They are norgestimate, desogestrel, and gestodene. Estrogen seems to cause vascular complications. ...They have littl …
They contain 1 of 5 synthetic progestogens (derived from 19-nortestosterone) and 1 of 2 estrogens. 3 new progestin compounds are in use in E …
Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate.
Schmitt-Hoffmann AH, Roos B, Sauer J, Schleimer M, Schoetzau A, Leese PT, Weidekamm E, Maares J. Schmitt-Hoffmann AH, et al. Clin Exp Dermatol. 2011 Apr;36 Suppl 2:4-11. doi: 10.1111/j.1365-2230.2011.04031.x. Clin Exp Dermatol. 2011. PMID: 21443598 Clinical Trial.
Similarly, the influence of ethinyl estradiol/norgestimate on systemic exposure to alitretinoin and 4-oxo-alitretinoin was not clinically relevant. Alitretinoin was well tolerated when given either alone or with ethinyl estradiol/norgestimate
Similarly, the influence of ethinyl estradiol/norgestimate on systemic exposure to alitretinoin and 4-oxo-alitretinoin …
251 results